Fate Therapeutics, Inc. · NASDAQ:FATE
Schonfeld Strategic Advisors LLC reported a 6.80% stake in Fate Therapeutics, Inc. (Schedule 13G)
Event Mar 31, 2025 · Filed May 15, 2025
Schonfeld Strategic Advisors LLC reported a 6.80% stake in Fate Therapeutics, Inc., 7,794,513 shares, as a passive investor on Mar 31, 2025. Filed May 15, 2025 (Schedule 13G).
- Stake
- 6.80%
- Shares
- 7,794,513
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Schonfeld Strategic Advisors LLC | 6.80% | 7,794,513 |
Source
Related
- Fate Therapeutics, Inc.
- Schonfeld Strategic Advisors LLC
- Fate Therapeutics, Inc. shareholders
- Schedule 13G/A · Schonfeld Strategic Advisors LLC · Aug 14, 2025
- Form 4 · Tahl Cindy · Aug 5, 2026
- Form 4 · Valamehr Bahram · Aug 5, 2026
- Schedule 13G/A · BlackRock, Inc. · Jul 8, 2026
- Form 4 · Tahl Cindy · May 21, 2026
- Form 4 · Valamehr Bahram · May 21, 2026